Tavalisse 150 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F45PX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,595
Award facts
- Contract value 100% obligated
- $19,595.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 150 mg, a pharmaceutical product used in the treatment of immune thrombocytopenia. This competitively awarded, non-set-aside contract was executed on November 10, 2025, with a firm fixed price ceiling value of $19,595.16 and an ultimate completion date of December 3, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement programs.
As a major pharmaceutical vendor supporting military and veteran healthcare systems, AmerisourceBergen leverages its comprehensive IDC to supply a broad range of medications, medical devices, and healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's performance of this delivery order is based in Conshohocken, Pennsylvania, where the pharmaceutical products are sourced and distributed. This award reflects AmerisourceBergen's ongoing role as a primary vendor within DLA's pharmaceutical supply chain and demonstrates the agency's continued reliance on the company to fulfill specialized medical procurement needs for the Department of Defense and its affiliated healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F45PX?
SPE2DR26F45PX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F45PX worth?
The government has obligated $19,595 on SPE2DR26F45PX.
Is contract SPE2DR26F45PX an order under another contract?
Yes. SPE2DR26F45PX is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F45PX competed?
The extent of competition for SPE2DR26F45PX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award